凝集素样氧化低密度脂蛋白受体1(LOX1)检测试剂盒(酶联免疫吸附试验法)

ELISA Kit for Lectin Like Oxidized Low Density Lipoprotein Receptor 1 (LOX1)

OLR1; CLEC8A; SCARE1; Oxidized low-density lipoprotein receptor 1; C-type lectin domain family 8 member A; Lectin-like oxidized LDL receptor 1; Lectin-type oxidized LDL receptor 1

  • 凝集素样氧化低密度脂蛋白受体1(LOX1)检测试剂盒(酶联免疫吸附试验法) 产品包装(模拟)
  • 凝集素样氧化低密度脂蛋白受体1(LOX1)检测试剂盒(酶联免疫吸附试验法) 产品包装(模拟)
  • 凝集素样氧化低密度脂蛋白受体1(LOX1)检测试剂盒(酶联免疫吸附试验法) 实验结果图
  • SEB859Hu.jpg 标准曲线图
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

本试剂盒用于检测凝集素样氧化低密度脂蛋白受体1(LOX1)，经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制，不可能完成对所有相关或相似物质交叉反应检测，因此本试剂盒有可能与未经检测的其它物质有交叉反应。

回收率

分别于定值血清及血浆样本中加入一定量的凝集素样氧化低密度脂蛋白受体1(LOX1)（加标样品），重复测定并计算其均值，回收率为测定值与理论值的比率。

样本 回收率范围(%) 平均回收率(%)
serum(n=5) 97-105 102
EDTA plasma(n=5) 88-97 92
heparin plasma(n=5) 78-99 94

精密度

精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差：取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次，分别计算不同浓度样本的平均值及SD值。
批间差：选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定，每个样本使用同一试剂盒重复测定8次，分别计算不同浓度样本的平均值及SD值。
批内差： CV<10%
批间差： CV<12%

线性

在定值血清及血浆样本内加入适量的凝集素样氧化低密度脂蛋白受体1(LOX1)，并倍比稀释成1:2，1:4，1:8，1:16的待测样本，线性范围即为稀释后样本中凝集素样氧化低密度脂蛋白受体1(LOX1)含量的测定值与理论值的比率。

样本 1:2 1:4 1:8 1:16
serum(n=5) 83-103% 92-99% 91-98% 96-105%
EDTA plasma(n=5) 84-92% 95-104% 89-101% 79-97%
heparin plasma(n=5) 99-105% 86-101% 87-103% 80-91%

稳定性

经测定，试剂盒在有效期内按推荐温度保存，其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响，实验室的环境条件需尽量保持一致，尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。

实验流程

1. 实验前标准品、试剂及样本的准备；
2. 加样（标准品及样本）100µL，37°C孵育1小时；
3. 吸弃，加检测溶液A100µL，37°C孵育1小时；
4. 洗板3次；
5. 加检测溶液B100µL，37°C孵育30分钟；
6. 洗板5次；
7. 加TMB底物90µL，37°C孵育10-20分钟；
8. 加终止液50µL，立即450nm读数。

实验原理

将凝集素样氧化低密度脂蛋白受体1(LOX1)抗体包被于96孔微孔板中，制成固相载体，向微孔中分别加入标准品或标本，其中的凝集素样氧化低密度脂蛋白受体1(LOX1)与连接于固相载体上的抗体结合，然后加入生物素化的凝集素样氧化低密度脂蛋白受体1(LOX1)抗体，将未结合的生物素化抗体洗净后，加入HRP标记的亲和素，再次彻底洗涤后加入TMB底物显色。TMB在过氧化物酶的催化下转化成蓝色，并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的凝集素样氧化低密度脂蛋白受体1(LOX1)呈正相关。用酶标仪在450nm波长下测定吸光度(O.D.值)，计算样品浓度。

相关产品

编号 适用物种：Homo sapiens (Human，人) 应用(仅供研究使用，不用于临床诊断！)
RPB859Hu01 凝集素样氧化低密度脂蛋白受体1(LOX1)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAB859Hu01 凝集素样氧化低密度脂蛋白受体1(LOX1)多克隆抗体 WB; ICC; IHC-P; IHC-F; ELISA.
MAB859Hu23 凝集素样氧化低密度脂蛋白受体1(LOX1)单克隆抗体 WB; IHC; ICC; IP.
MAB859Hu21 凝集素样氧化低密度脂蛋白受体1(LOX1)单克隆抗体 WB; IHC; ICC; IP.
MAB859Hu22 凝集素样氧化低密度脂蛋白受体1(LOX1)单克隆抗体 WB; IHC; ICC; IP.
MAB859Hu24 凝集素样氧化低密度脂蛋白受体1(LOX1)单克隆抗体 WB; IHC; ICC; IP.
SEB859Hu 凝集素样氧化低密度脂蛋白受体1(LOX1)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB859Hu 凝集素样氧化低密度脂蛋白受体1(LOX1)等多因子检测试剂盒(流式荧光发光法) FLIA Kit for Antigen Detection.
KSB859Hu01 凝集素样氧化低密度脂蛋白受体1(LOX1)检测试剂盒DIY材料(酶联免疫吸附试验法) Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志 参考文献
Clinical Cardiology Circulating Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels Are Associated With Angiographic Coronary Lesion Complexity in Patients With Coronary Artery Diseas [PubMed: 21400544]
Coronary Artery Disease Postprocedural serum sLOX-1 levels are associated with coronary in-stent restenosis in patients with stable coronary artery disease [LWW: 06000]
Clinical Biochemistry Soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in synovial fluid are correlated with disease severity of knee osteoarthritis [ScienceDirect: S0009912011004905]
Mediators of Inflammation Pregnancy Followed by Delivery May Affect Circulating Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels in Women of Reproductive Age [PubMed: 22619487]
Dicle Medical Journal Lectin-like oxidized low density lipoprotein receptor 1(LOX-1) levels and endothelial dysfunction in patients with primary essential hyperhidrosis/Primer esansiyel hiperhidroz hastalarinda lektin benzeri okside düsük dansiteli lipoprotein reseptor 1(LOX-1) düzeyleri ve endotel disfonksiyonu [Readperiodicals: Source]
Journal of Clinical Laboratory Analysis Soluble Lectin-Like Oxidized LDL Receptor 1 as a Possible Mediator of Endothelial Dysfunction in Patients With Metabolic Syndrome [Pubmed:24798146]
Journal of Human Hypertension Endothelial damage in white coat hypertension: role of lectin-like oxidized low-density lipoprotein-1 [Pubmed:25007999]
Gynecologic and Obstetric Investigation Inhibition of Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Protects against Plasma/Hypoxia-Mediated Trophoblast Dysfunction Associated with Preeclampsia [Pubmed:25633310]
World J Gastroenterol Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease [PubMed: 26185381]
Genetic Testing and Molecular Biomarkers Serum sLOX-1 Levels Are Correlated with the Presence and Severity of Obstructive Sleep Apnea [PubMed: 25825846]
Neurotoxicology. 27-Hydroxycholesterol regulates cholesterol synthesis and transport in C6 glioma cells. [pubmed:28167099]
Journal of the American Heart Association Increased Levels of Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor‐1 in Ischemic Stroke and Transient Ischemic Attack [Pubmed:29330254]
Higher serum lectin-like oxidized low-density lipoprotein receptor-1 in patients with stable coronary artery disease is associated with major adverse … []
Disease Markers Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous … [Pubmed: 31772687]
Reproductive Biology Polycystic ovary syndrome and endothelial dysfunction: A potential role for soluble lectin-like oxidized low density lipoprotein receptor-1 [Pubmed: 32409108]
Int J Cancer The oxidized‐LDL/LOX‐1 axis in tumor endothelial cells enhances metastasis by recruiting neutrophils and cancer cells [Pubmed:35608341]
留言咨询